YHB Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$528K Buy
5,104
+70
+1% +$6.25K 0.03% 213
2026
Q1
$362K Sell
5,034
-166
-3% -$12.8K 0.03% 233
2025
Q4
$413K Sell
5,200
-935
-15% -$73.7K 0.03% 224
2025
Q3
$463K Sell
6,135
-125
-2% -$8.57K 0.03% 215
2025
Q2
$432K Sell
6,260
-700
-10% -$45.9K 0.03% 222
2025
Q1
$472K Sell
6,960
-5,385
-44% -$322K 0.04% 208
2024
Q4
$554K Sell
12,345
-1,245
-9% -$69.8K 0.05% 192
2024
Q3
$855K Sell
13,590
-785
-5% -$45.8K 0.07% 157
2024
Q2
$849K Sell
14,375
-648
-4% -$40.5K 0.07% 155
2024
Q1
$1.2M Sell
15,023
-349
-2% -$26.7K 0.11% 142
2023
Q4
$1.21M Sell
15,372
-9,844
-39% -$701K 0.12% 135
2023
Q3
$1.76M Sell
25,216
-7,617
-23% -$540K 0.16% 121
2023
Q2
$2.27M Sell
32,833
-47,637
-59% -$3.39M 0.21% 107
2023
Q1
$5.98M Sell
80,470
-383
-0.5% -$32.1K 0.6% 48
2022
Q4
$7.53M Sell
80,853
-1,216
-1% -$117K 0.8% 35
2022
Q3
$7.83M Buy
82,069
+133
+0.2% +$13.2K 0.87% 29
2022
Q2
$7.59M Sell
81,936
-1,741
-2% -$170K 0.8% 35
2022
Q1
$8.47M Sell
83,677
-8,643
-9% -$908K 0.75% 38
2021
Q4
$9.52M Sell
92,320
-142
-0.2% -$13.1K 0.75% 37
2021
Q3
$7.85M Buy
92,462
+164
+0.2% +$13.7K 0.68% 40
2021
Q2
$7.7M Sell
92,298
-438
-0.5% -$35.9K 0.66% 42
2021
Q1
$7.04M Buy
92,736
+2,120
+2% +$154K 0.61% 45
2020
Q4
$6.19M Sell
90,616
-228
-0.3% -$14.8K 0.59% 46
2020
Q3
$5.3M Sell
90,844
-25,523
-22% -$1.59M 0.58% 47
2020
Q2
$7.56M Buy
116,367
+990
+0.9% +$62.3K 1.09% 28
2020
Q1
$6.84M Buy
115,377
+3,064
+3% +$205K 1.18% 28
2019
Q4
$8.34M Buy
112,313
+235
+0.2% +$16.5K 1.19% 25
2019
Q3
$7.07M Buy
112,078
+8,092
+8% +$480K 1.08% 29
2019
Q2
$5.67M Buy
103,986
+5,467
+6% +$294K 0.9% 36
2019
Q1
$5.31M Sell
98,519
-1,863
-2% -$115K 0.83% 38
2018
Q4
$6.58M Buy
100,382
+11,675
+13% +$872K 1.18% 26
2018
Q3
$6.98M Sell
88,707
-306
-0.3% -$21.9K 1.05% 28
2018
Q2
$5.73M Sell
89,013
-1,266
-1% -$83.4K 0.94% 32
2018
Q1
$5.62M Sell
90,279
-221
-0.2% -$15.9K 0.95% 30
2017
Q4
$6.56M Sell
90,500
-3,373
-4% -$245K 1.12% 26
2017
Q3
$7.63M Sell
93,873
-8,996
-9% -$712K 1.37% 22
2017
Q2
$8.28M Buy
102,869
+9,822
+11% +$776K 1.42% 22
2017
Q1
$7.67M Buy
93,047
+366
+0.4% +$29.2K 1.47% 18
2016
Q4
$7.31M Buy
92,681
+5,138
+6% +$416K 1.52% 17
2016
Q3
$7.79M Sell
87,543
-5,825
-6% -$550K 1.88% 13
2016
Q2
$8.94M Buy
93,368
+4,926
+6% +$491K 1.97% 9
2016
Q1
$9.17M Sell
88,442
-3,426
-4% -$333K 2.48% 7
2015
Q4
$8.98M Buy
91,868
+1,485
+2% +$145K 2.04% 11
2015
Q3
$8.72M Buy
90,383
+178
+0.2% +$18.7K 2.06% 12
2015
Q2
$9.46M Buy
90,205
+888
+1% +$90.7K 2.06% 10
2015
Q1
$9.22M Sell
89,317
-868
-1% -$87.8K 2.07% 12
2014
Q4
$8.69M Sell
90,185
-539
-0.6% -$47.5K 1.99% 12
2014
Q3
$7.22M Sell
90,724
-533
-0.6% -$42K 1.73% 14
2014
Q2
$6.88M Sell
91,257
-171
-0.2% -$12.9K 1.66% 16
2014
Q1
$6.84M Buy
91,428
+3,982
+5% +$281K 1.74% 12
2013
Q4
$6.26M Buy
87,446
+407
+0.5% +$26.1K 1.68% 13
2013
Q3
$4.94M Sell
87,039
-705
-0.8% -$42K 1.46% 19
2013
Q2
$5.02M Buy
+87,744
New +$5.08M 1.56% 17

Other funds holding CVS

YHB Investment Advisors's CVS Position: Q2 2026 in Review

YHB Investment Advisors increased its CVS Health (CVS) stake by 1.4% in Q2 2026, buying an estimated $6.25K and bringing the position to 5,104 shares worth $528K. The position accounts for 0.03% of the portfolio, ranked #213.

YHB Investment Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.52M in Q4 2021. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • YHB Investment Advisors held 5,104 shares of CVS Health worth $528K as of Q2 2026.
  • YHB Investment Advisors bought 70 CVS Health shares in Q2 2026, an estimated $6.25K.
  • CVS Health made up 0.03% of YHB Investment Advisors's portfolio in Q2 2026, its #213 holding.
  • YHB Investment Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • YHB Investment Advisors's CVS Health position peaked at $9.52M in Q4 2021.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.